Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Malkin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Neuro-Oncology|November 23, 2001
A phase II trial of temozolomide for patients with recurrent or progressive brain metastasesL E Abrey, J D Olson, J J Raizer, et al.
Neurology|April 24, 2002
Handheld cellular telephones and risk of acoustic neuromaJ E Muscat, M G Malkin, R E Shore, et al.
JAMA|December 21, 2000
Handheld cellular telephone use and risk of brain cancerJ E Muscat, M G Malkin, S Thompson, et al.
Neurology|September 1, 1991
Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrationsR K Portenoy, E Khan, M Layman, et al.
Mayo Clinic Proceedings|March 9, 1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent gliomaJ C Buckner, M G Malkin, E Reed, et al.
Journal of Neuro-Oncology|January 1, 1994
Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study GroupM G Malkin, S B Green, D P Byar, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Safe and cost effective use of alteplase for the clearance of occluded central venous access devicesJ P Timoney, M G Malkin, D M Leone, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Neuro-Oncology|November 23, 2001
A phase II trial of temozolomide for patients with recurrent or progressive brain metastasesL E Abrey, J D Olson, J J Raizer, et al.
Neurology|April 24, 2002
Handheld cellular telephones and risk of acoustic neuromaJ E Muscat, M G Malkin, R E Shore, et al.
JAMA|December 21, 2000
Handheld cellular telephone use and risk of brain cancerJ E Muscat, M G Malkin, S Thompson, et al.
Neurology|September 1, 1991
Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrationsR K Portenoy, E Khan, M Layman, et al.
Mayo Clinic Proceedings|March 9, 1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent gliomaJ C Buckner, M G Malkin, E Reed, et al.
Journal of Neuro-Oncology|January 1, 1994
Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study GroupM G Malkin, S B Green, D P Byar, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Safe and cost effective use of alteplase for the clearance of occluded central venous access devicesJ P Timoney, M G Malkin, D M Leone, et al.
Pageof 3